Finance

Beta
Lists
FHTX:NASDAQ
Foghorn Therapeutics Inc
$4.22
+4.71%
(+0.19) 1D
$4.22
-0.00% (-0.000100)
After hours
Closed: Jun 26, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for FHTX...
Open
$4.01
High
$4.29
Low
$3.98
Mkt. cap
247.77M
Avg. vol.
163.58K
Volume
1.23M
52-wk high
$6.95
52-wk low
$3.27
EPS
-$1.17
Beta
2.89
Shares outstanding
58.71M
No. of employees
106
Open
$4.01
High
$4.29
Low
$3.98
Mkt. cap
247.77M
Avg. vol.
163.58K
Volume
1.23M
52-wk high
$6.95
52-wk low
$3.27
EPS
-$1.17
Beta
2.89
Shares outstanding
58.71M
No. of employees
106
News stories
From sources across the web
About Foghorn Therapeutics Inc
CEO-
Employees106
Founded2015
Headquarters-
SectorBiotechnology
Websitefoghorntx.com
Analyst ratings
Based on 5 analysts giving stock ratings to FHTX in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for FHTX in the last 3 months.
Highest
Current $4.22
$13.00 (+208.06%)
Average
$11.75 (+178.44%)
Lowest
$10.00 (+136.97%)
Analyst
Recommendation
Action
Price target
Projected
Date
Laura Prendergast
Stifel Nicolaus
Buy
Maintained
$12.00
+184.4%
06/01/2026
Robert Driscoll
Wedbush
Buy
Reiterated
$10.00
+137%
05/08/2026
Unknown Analyst
Guggenheim
Buy
Maintained
$12.00
+184.4%
05/07/2026
Andres Y. Maldonado
H.C. Wainwright
Buy
Reiterated
$13.00
+208.1%
05/08/2026
Yaron Werber
TD Cowen
Buy
Maintained
-
-
05/07/2026
Michael Schmidt
Guggenheim
Buy
Maintained
$12.00
+184.4%
03/11/2026
Jeet Mukherjee
BTIG
Buy
Maintained
$11.00
+160.7%
03/11/2026
Amin Makarem
Jefferies
Buy
Maintained
$12.00
+184.4%
02/16/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
7.56M
8.15M
9.25M
3.27M
Cost of goods sold
21.79M
20.00M
22.05M
18.26M
Cost of revenue
21.79M
20.00M
22.05M
18.26M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.86M
6.65M
6.80M
6.58M
Operating expense
6.86M
6.65M
6.80M
6.58M
Total operating expenses
28.65M
26.65M
28.84M
24.84M
Operating income
-21.10M
-18.50M
-19.60M
-21.57M
Other non operating income
852.00K
620.00K
502.00K
-44.00K
EBT including unusual items
-17.94M
-15.85M
-21.66M
-19.88M
EBT excluding unusual items
-17.94M
-15.85M
-17.38M
-19.88M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-17.94M
-15.85M
-21.66M
-19.88M
Net profit margin
-237.34%
-194.39%
-234.28%
-608.36%
Earnings per share
-0.28
-0.25
-0.37
-0.29
Interest and investment income
2.31M
2.03M
1.71M
1.74M
Interest expense
-
-
-
-
Net interest expenses
2.31M
2.03M
1.71M
1.74M
Depreciation and amortization charges
-
-
-
-
EBITDA
-20.25M
-17.65M
-18.79M
-21.34M
Gain or loss from assets sale
-
-
31.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of FHTX
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer